Community post

Repurposing CRISPR systems as antimicrobials is a new strategy being explored, and engineered phages could be a great way to carry them to their targets. Clément Fage (Université Laval, Canada) and colleagues published a new perspective in Current Opinion in Biotechnology on the delivery of CRISPR-Cas systems using phage-based vectors.